Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 30 January 2023 31 January 2024 31 January 2024 14626330 Dr Ellie Suh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14626330 2023-01-29 14626330 2024-01-31 14626330 2023-01-30 2024-01-31 14626330 frs-core:CurrentFinancialInstruments 2024-01-31 14626330 frs-bus:PrivateLimitedCompanyLtd 2023-01-30 2024-01-31 14626330 frs-bus:FilletedAccounts 2023-01-30 2024-01-31 14626330 frs-bus:Micro-entities 2023-01-30 2024-01-31 14626330 frs-bus:AuditExempt-NoAccountantsReport 2023-01-30 2024-01-31 14626330 frs-bus:Director1 2023-01-30 2024-01-31
Registered number: 14626330
East London Research Co Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2024
Balance Sheet
Registered number: 14626330
2024
£
Current assets 27,745
Creditors: Amounts Falling Due Within One Year (5,601 )
NET CURRENT ASSETS 22,144
TOTAL ASSETS LESS CURRENT LIABILITIES 22,144
Accruals and deferred income (299 )
NET ASSETS 21,845
CAPITAL AND RESERVES 21,845

Notes

1. General Information
East London Research Co Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14626330 . The registered office is Flat 7 Adrian Boult House, 125 Mansford Street, London, E2 6NQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Ellie Suh
Director
25th October 2024